Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Thoracic Cancer|November 4, 2025
Intrapleural Administration of Hypotonic Cisplatin for Patients With Malignant Pleural Effusions and Non-Expandable LungsWataru Mori, Tomoyasu Mimori, Jun Ito, et al.
Nutrients|October 16, 2024
Association between Poor Outcomes and Risk of Refeeding Syndrome among Patients Urgently Admitted to the High Dependency Unit: A Single-Center Cohort Study in JapanMinoru Yoshida, Masako Suzuki, Haruaki Wakatake, et al.
Acute Medicine & Surgery|January 29, 2020
Clinical outcomes of urinary tract infection caused by extended spectrum beta-lactamase producing Enterobacteriaceae: a retrospective observational study comparing patients with and without systemic inflammatory response syndromeYuka Kitano, Haruaki Wakatake, Hiroki Saito, et al.
Acute Medicine & Surgery|November 12, 2024
Use of an eligibility checklist on arrival of emergency room as a registry system for corneal donation-A 9-year retrospective cohort studyHaruaki Wakatake, Koichi Hayashi, Miyuki Kurisu, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 24, 2020
Mortality associated with new risk classification of developing refeeding syndrome in critically ill patients: A cohort studyMinoru Yoshida, Junichi Izawa, Haruaki Wakatake, et al.
Thoracic Cancer|June 5, 2025
Successful Treatment of HER2 V659E Mutation-Positive Lung Adenocarcinoma With Trastuzumab Deruxtecan: A Case ReportMariko Nishihara, Yuki Shinno, Yoshihiro Masui, et al.
Neurocritical Care|October 3, 2018
Association Between Therapeutic Hypothermia and Outcomes in Patients with Non-shockable Out-of-Hospital Cardiac Arrest Developed After Emergency Medical Service Arrival (SOS-KANTO 2012 Analysis Report)Minoru Yoshida, Toru Yoshida, Yoshihiro Masui, et al.
IEEE Transactions on Biomedical Circuits and Systems|October 7, 2020
CMOS Gaussian Monocycle Pulse Transceiver for Radar-Based Microwave ImagingTakamaro Kikkawa, Yoshihiro Masui, Akihiro Toya, et al.
Journal for Immunotherapy of Cancer|June 29, 2026
Pharmacokinetic variability with pembrolizumab dosage switching and its impact on immune-related adverse events in patients with non-small cell lung cancerRyoko Inaba Higashiyama, Tatsuya Yoshida, Shigehiro Yagishita, et al.
Thoracic Cancer|October 8, 2024
Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapyYoshihiro Masui, Takehito Shukuya, Shunichi Kataoka, et al.
Pageof 3